Business

Mass. Movers

Harvard Bioscience stock

Harvard Bioscience develops tools for life-sciences research and regenerative medicine.

Essdras M Suarez/Globe Staff/File 2011

Harvard Bioscience develops tools for life-sciences research and regenerative medicine.

Advertisement

Harvard Bioscience Inc.’s shares rose 11 cents to $5.01. It’s board of directors this week elected Jeffrey A. Duchemin as chief executive of the Holliston company. The interim CEO, David Green, will continue as president until the spin-off of the regenerative medicine subsidiary, which Green will head. Most recently, Duchemin was global business director for Corning Life Sciences.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.